The financials
Acadia Healthcare Company, Inc. by the numbers
Acadia Healthcare Company, Inc. (ACHC) reported revenue of $829M in Q1 2026 (quarter ended Mar 31, 2026), up 7.6% from the same quarter a year earlier. That came with net income of $4.1M (0.5% of revenue). For the full year FY2025, revenue was $3.31B (+5.0% year on year) and net income −$1.10B. Its largest product in Jun 2026 was Acute Inpatient Psychiatric Facilities at $495M, 57% of the disclosed total, well ahead of Comprehensive Treatment Centers at 16%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $829M | $771M | +7.6% |
| Operating income | $11M | $13M | −19% |
| Net income | $4.1M | $8.4M | −51% |
| Diluted EPS | $0.05 | $0.09 | −44% |
| Product | Revenue | Share |
|---|---|---|
| Acute Inpatient Psychiatric Facilities | $495M | 57% |
| Comprehensive Treatment Centers | $141M | 16% |
| Specialty Treatment Facilities | $134M | 15% |
| Residential Treatment Centers | $97M | 11% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $865.8M (+4.5%)
Residential Treatment Centers grew +12% year on yearSpecialty Treatment Facilities -8.4% year on year
Segment Latestquarter on quarteryear on year
- Acute Inpatient Psychiatric Facilities$494.6M$494.6MQoQ +5.1%year on year -0.17%+5.1%-0.17%
- Comprehensive Treatment Centers$141.2M$141.2MQoQ +0.55%year on year -0.24%+0.55%-0.24%
- Specialty Treatment Facilities$133.5M$133.5MQoQ +4.2%year on year -8.4%+4.2%-8.4%
- Residential Treatment Centers$96.6M$96.6MQoQ +7.8%year on year +12%+7.8%+12%